NCCM
INFI

Nine Chapters Capital Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Nine Chapters Capital Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-91,500
Closed -$296K – 197
2017
Q1 		$296K Sell
91,500
-5,100
-5% -$12.5K 0.4% 104
2016
Q4 		$130K Buy
96,600
+86,500
+856% +$113K 0.22% 136
2016
Q3 		$16K Buy
+10,100
New +$15.5K 0.11% 69
2015
Q4 		– Sell
-190,200
Closed -$1.61M – 624
2015
Q3 		$1.61M Buy
190,200
+75,700
+66% +$698K 0.14% 202
2015
Q2 		$1.25M Buy
114,500
+18,200
+19% +$234K 0.11% 280
2015
Q1 		$1.35M Sell
96,300
-1,100
-1% -$16.8K 0.11% 266
2014
Q4 		$1.65M Buy
97,400
+35,700
+58% +$520K 0.14% 198
2014
Q3 		$828K Buy
61,700
+46,600
+309% +$555K 0.07% 356
2014
Q2 		$192K Buy
+15,100
New +$157K 0.02% 831

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Nine Chapters Capital Management's INFI Position: Q2 2017 in Review

Nine Chapters Capital Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2017, closing a stake of 91,500 shares — an estimated $296K sold.

Nine Chapters Capital Management first reported a position in INFI in Q2 2014 and held it in 9 quarters. The position peaked at $1.65M in Q4 2014. 74 funds tracked by Wall St. Rank hold INFI as of Q2 2017.

  • Nine Chapters Capital Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • Nine Chapters Capital Management sold 91,500 Infinity Pharmaceuticals, Inc. shares in Q2 2017, an estimated $296K.
  • Nine Chapters Capital Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2014 and held it in 9 quarters.
  • Nine Chapters Capital Management's Infinity Pharmaceuticals, Inc. position peaked at $1.65M in Q4 2014.
  • 74 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2017.

Based on Nine Chapters Capital Management's 13F filing for Q2 2017, filed 31 Jul 2017.